Day: December 17, 2025

Major shareholder announcement – Fagligt Fælles Forbund

Written by Customer Service on December 17, 2025. Posted in Public Companies.

Company Announcement No 68/2025Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 AL Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk17 December 2025 Dear Sirs Major shareholder announcement – Fagligt Fælles Forbund With reference to section 30, cf. section 38, of the Danish Capital Markets Act this is to announce that on 17 December 2025 AL Sydbank was informed that, as at 12 December 2025, the direct holdings of Fagligt Fælles Forbund, 31378028, Kampmannsgade 4, 1604 København V. represent 12.61% of the voting rights and 12.61% of the share capital of AL Sydbank A/S. Kind regards AL Sydbank A/SAttachmentSM 68 UK

Danone SA announces the purchase of c.5.8 million of its own shares held by its Spanish subsidiary, with no impact on total Danone shares held by the Group

Written by Customer Service on December 17, 2025. Posted in Public Companies.

Press release – Paris, December 17, 2025, at 7:00 PM CET Danone SA announces the purchase of c.5.8 million of its own shares held by its Spanish subsidiary, with no impact on total Danone shares held by the GroupAs part of the simplification of its corporate structure, Danone SA purchased on December 17, 2025, all 5,780,005 of its own shares previously held by its Spanish subsidiary, Danone Spain. This transaction has no impact on the total Danone shares held by the Group. These shares, purchased at a price equal to the closing stock price as of December 17, 2025 (i.e. €77.46), have been allocated to employee shareholding plans. This transaction was implemented in the framework of the authorization granted by the Shareholders’ Meeting of April 24, 2025. About Danone...

ArrowMark Financial Corp. Announces Monthly Cash Distribution Schedule for 2026

Written by Customer Service on December 17, 2025. Posted in Dividend Reports And Estimates.

DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (Nasdaq: BANX) (“ArrowMark Financial” or the “Company”), an SEC registered closed-end management investment company, announced that its Board of Directors has approved a change in the Fund’s cash distribution frequency from quarterly to monthly, beginning with the January distribution. “We are pleased to announce the transition to a monthly distribution schedule,” said Chairman & CEO Sanjai Bhonsle, “This change reflects the Fund’s income-generating profile and aligns with our objective of delivering consistent income while preserving capital and generating attractive risk-adjusted returns for our shareholders.” About ArrowMark Financial Corp. ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select...

Solvay Financial Calendar 2026

Written by Customer Service on December 17, 2025. Posted in Public Companies.

Press release Regulated information Brussels, December 17, 2025, 5.45pm CET Solvay today publishes its 2026 financial calendar.Event DateInterim dividend: ex-date January 19, 2026Interim dividend: payment date January 21, 2026Fourth quarter and full year 2025 earnings February 24, 2026First quarter 2026 earnings May 7, 2026Ordinary General Shareholders’ Meeting May 12, 2026Second quarter and first half year 2026 earnings July 29, 2026Third quarter and first nine months 2026 earnings November 4, 2026Quiet period dates will be provided prior to each earnings’ season.We invite you to join our mailing list to receive events notifications. More information can be found on www.solvay.com/en/investors Contacts Investor relations Geoffroy d’Oultremont:...

Transgene to Participate in Upcoming Investor Meetings

Written by Customer Service on December 17, 2025. Posted in Public Companies.

Strasbourg (France), December 17, 2025, 17:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:LifeSci Partners Corporate Access Event (by LifeSci Partners), on January 12 and 13, 2026, in San Francisco (United States) in conjunction with the JP Morgan Healthcare Conference; Biomed Forum (by Allinvest Securities), on January 29, 2026, in Paris (France).*** ContactsTransgene: Media: Investors & Analysts:Caroline Tosch Lucie LarguierCorporate and Scientific Communications Manager Chief Financial Officer (CFO)+33 (0)3 68 33 27 38 Nadege Bartolicommunication@transgene.fr Investor Relations Analystand Financial Communications...

Nexans Completes Acquisition of Electro Cables Inc. to Strengthen Low-Voltage Solutions (PWR-CONNECT) in North America

Written by Customer Service on December 17, 2025. Posted in Mergers And Acquisitions.

Nexans Completes Acquisition of Electro Cables Inc. to Strengthen Low-Voltage Solutions (PWR-CONNECT) in North America Paris, December 17th, 2025 – Nexans announces today the completion of the acquisition of Electro Cables Inc. (“Electro Cables”), a well-positioned Canadian manufacturer of low-voltage cable systems, in a strategic move that expands the company’s footprint in one of North America’s most dynamic segments. The acquisition marks a significant milestone in Nexans’ strategy to accelerate growth in North America and supports the region’s fast-expanding infrastructure, data center, and energy sectors. Following today’s completion, a team of roughly 200 highly skilled associates will join the Nexans Group. Electro Cables generated approximately 125 million euros in revenue over the twelve months ending July 2025. This acquisition...

Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours

Written by Customer Service on December 17, 2025. Posted in Public Companies.

On track for initial clinical data in mid-2026 Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumoursOslo, Norway, 17 December 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic off-the-shelf cell therapies for cancer, today announced the submission of its Clinical Trial Application (CTA) to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ZI-MA4-1, the Company’s lead candidate. The CTA submission marks Zelluna’s transition from preclinical to clinical development and represents the successful delivery of all key milestones communicated for 2025:Manufacturing process locked (April 2025) Preclinical data package completed and key data published (December 2025) GMP clinical batch produced and quality-tested (December 2025) Clinical Trial Application submitted to...

Vishay Intertechnology Introduces Thin Film Chip Fuses With Fast and Very Fast Acting Performance

Written by Customer Service on December 17, 2025. Posted in Public Companies.

S2F and S3F Series Thin Film Chip Fuses in 0402, 0603, and 1206 Sizes Provide Protection From 0.315 A to 7 A, With UL 248-14 Compliance and Low Resistance MALVERN, Pa., Dec. 17, 2025 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced two new series of thin film chip fuses. The Vishay Sfernice S2F and S3F devices are designed to ensure circuit continuity with minimal resistance and reliable interruption under overload conditions, while providing designers with options for fast or very fast acting protection. Offered in 0402, 0603, and 1206 case sizes, the fuses are UL 248-14 compliant and cover rated currents from 0.315 A to 7 A. Both series combine low resistance with body temperature rise below 75 °C at 100 % rated current, ensuring high reliability in compact footprints. The devices are lead (Pb)-free,...

Update Statement on 2025 Annual General Meeting Voting Results

Written by Customer Service on December 17, 2025. Posted in Public Companies.

Octopus Titan VCT plc Update Statement on 2025 Annual General Meeting Voting Results At the Annual General Meeting of Octopus Titan VCT plc (the ‘Company’ or ‘Titan’), held on 19 June 2025, more than 20 percent of the votes were cast against the Board recommendation for Resolutions 2, 3 and 4; the resolutions for the approval of the Directors’ Remuneration report and the re-election of Jane O’Riordan and Lord Rockley respectively. Provision 4 of the AIC Code of Corporate Governance 2024 (the ‘Code’), states that when 20 percent or more of votes have been cast against the Board recommendation for a resolution, the Company should publish an update on the views received from shareholders no later than six months after the shareholder meeting. In accordance with the Code, the Board confirms that it endeavoured to contact those shareholders...

Central Government Borrowing Strategy 2026

Written by Customer Service on December 17, 2025. Posted in Public Companies.

The strategy update for the central government’s 2026 has now been published. The key messages in the strategy are: Target for domestic bond issuance of kr. 65 billion The target for issuance of government bonds is kr. 65 billion in 2026. The focus will continue to be on issuance in the nominal 2-year and 10-year maturity segments, supplemented with issuance in the green bond, the 30-year bond and the central government’s inflation-linked government bond programme. Opening of a new 2-year government bond In January 2026, a new 2-year government bond will be opened via auction maturing in 2028. The new government bond will replace DGB 0.50 per cent 2027 as the 2-year bond and will be continuously built up via auction and tap. Continuous issuance in central government’s green bond programme The central government’s...

Day: December 17, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals